Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries. Read More
One of the first global companies to break all the critical barriers of taste, price, and shelf-stability at room temperature, GoodDot is perfectly poised for explosive growth with the help of this investment and support from Sixth Sense Venture, Ind ...
The production of Russia's coronavirus vaccine Sputnik V in India is expected to come fully on stream in September, the Russian Direct Investment Fund (RDIF) informed on Saturday. ...
Urging Opposition not to make crisis a reason for politics, Union Health Minister Mansukh Mandaviya on Tuesday said the Indian government was not responsible for fudging of COVID-19 fatality data as state governments were responsible for it. ...
France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country. ...
Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said he it was good news that Covishield, the Indian version of the 16 European countries now recognised and accepted Oxford-Astrazeneca vaccine for entry of in ...
Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said he it was good news that Covishield, the Indian version of the 16 European countries now recognised and accepted Oxford-Astrazeneca vaccine for entry of in ...